Cigna (NYSE:CI) showed a loss in earnings since Q3, totaling $1.51 billion. Sales, on the other hand, increased by 2.13% to $41.67 billion during Q4. In Q3, Cigna earned $2.14 billion and total sales reached $40.80 billion.
Looking at Q4, Yum Brands (NYSE:YUM) earned $478.00 million, a 3.46% increase from the preceding quarter. Yum Brands also posted a total of $1.74 billion in sales, a 20.37% increase since Q3. Yum Brands earned $462.00 million, and sales totaled $1.45 billion in Q3.
CVS Health (NYSE:CVS) showed a loss in earnings since Q3, totaling $2.28 billion. Sales, on the other hand, increased by 3.73% to $69.55 billion during Q4. In Q3, CVS Health earned $3.04 billion and total sales reached $67.06 billion.
Southern (NYSE:SO) posted Q4 earnings of $703.00 million, an increase from Q3 of 61.69%. Sales dropped to $5.12 billion, a 8.95% decrease between quarters. In Q3, Southern earned $1.83 billion, and total sales reached $5.62 billion.
Cardlytics (NASDAQ:CDLX) reported Q4 sales of $67.08 million. Earnings fell to a loss of $6.12 million, resulting in a 62.1% decrease from last quarter. In Q3, Cardlytics brought in $46.08 million in sales but lost $16.14 million in earnings.
Looking at Q4, HCA Healthcare (NYSE:HCA) earned $2.45 billion, a 85.75% increase from the preceding quarter. HCA Healthcare also posted a total of $14.29 billion in sales, a 7.38% increase since Q3. In Q3, HCA Healthcare earned $1.32 billion, and total sales reached $13.31 billion.
During Q4, Raytheon Technologies (NYSE:RTX) brought in sales totaling $16.42 billion. However, earnings decreased 271.2%, resulting in a loss of $743.00 million. In Q3, Raytheon Technologies earned $434.00 million and total sales reached $14.75 billion.
Kymera Therapeutics's Stock Price And Volume Action
Kymera Therapeutics (NASDAQ:KYMR) is currently up 16.55% to a price of $35.68. The stock's current volume for the day is 161.51 thousand, which is approximately 31.2% of its previous 30-day average volume of 517.65 thousand.